Beneficient director buys 18,868 shares at $1.06
A Beneficient director reported an open-market stock purchase and now holds a larger direct position plus additional indirect equity interests through controlled entities.
Rhea-AI Filing Summary
Beneficient (BENF) director Peter T. Cangany, Jr. purchased 18,868 shares of Class A Common Stock on September 15, 2026 at $1.06 per share in a direct open-market or private transaction. Following this purchase, he directly holds 98,529 shares, including shares issuable upon settlement of RSU and REU awards under the company’s 2018 and 2023 equity incentive plans, and also has additional indirect holdings through entities he controls, for which beneficial ownership is partially disclaimed.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 18,868 shares
Net Buy
3 txns
Insider
CANGANY PETER T JR
Role
Director
Bought
18,868 shs ($20K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Class A Common Stock F1, F2, F3 | 18,868 | $1.06 | $20K |
| holding | Class A Common Stock F4 | -- | -- | -- |
| holding | Class A Common Stock F5 | -- | -- | -- |
Holdings After Transaction:
Class A Common Stock — 98,529 shares (Direct);
Class A Common Stock — 40,625 shares (Indirect, By Cangany Capital Management, LLC);
Class A Common Stock — 12,500 shares (Indirect, By The Cangany Group, LLC)
Footnotes (5)
- F1. Includes 80 shares of Class A common stock, par value $0.001 per share (the "Class A common stock"), of Beneficient (the "Issuer") issuable upon the settlement of an award of 80 restricted stock units ("RSUs") granted pursuant to Beneficient 2023 Equity Incentive Plan ("2023 Equity Incentive Plan") to Peter T. Cangany, Jr. (the "Reporting Person") on July 15, 2023. Such award of RSUs to the Reporting Person vested 20% on each of September 1, 2023, 2024, 2025, 2026, and the remaining 20% will vest on September 1, 2027.
- F2. Includes 97 shares of Class A common stock issuable upon the settlement of an award of 78 restricted equity units ("REUs") granted pursuant to The Beneficient Company Group, L.P. 2018 Equity Incentive Plan ("2018 Equity Incentive Plan") to the Reporting Person on April 25, 2019. Such award of REUs to the Reporting Person vested 25% on the date of grant and in 25% installments on April 1, 2020, 2021 and 2022.
- F3. Includes 23 shares of Class A common stock issuable upon settlement of an award of 18 REUs granted to the Reporting Person pursuant to the 2018 Equity Incentive Plan on April 1, 2022. Such award of REUs to the Reporting Person vested 40% on June 8, 2023 and in 20% installments on April 1, 2024, 2025 and 2026.
- F4. These shares of Class A common stock are directly held by Cangany Capital Management, LLC, a limited liability company controlled by the Reporting Person. The Reporting Person may be deemed to beneficially own securities of the Issuer held by such limited liability company. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or for any other purpose.
- F5. These shares of Class A common stock are directly held by The Cangany Group, LLC, a limited liability company controlled by the Reporting Person. The Reporting Person may be deemed to beneficially own securities of the Issuer held by such limited liability company. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Exchange Act or for any other purpose.
Key Figures
Shares purchased: 18,868 shares
Purchase price per share: $1.06 per share
Direct holdings after transaction: 98,529 shares
+5 more
8 metrics
Shares purchased
18,868 shares
Class A Common Stock bought on September 15, 2026
Purchase price per share
$1.06 per share
Open-market or private transaction on September 15, 2026
Direct holdings after transaction
98,529 shares
Class A Common Stock directly held after the September 15, 2026 purchase
Indirect holdings via Cangany Capital Management, LLC
40,625 shares
Class A Common Stock held indirectly through Cangany Capital Management, LLC
Indirect holdings via The Cangany Group, LLC
12,500 shares
Class A Common Stock held indirectly through The Cangany Group, LLC
RSUs included in direct holdings
80 RSUs
Shares issuable from RSUs granted July 15, 2023 under the 2023 Equity Incentive Plan
REU-related shares from 2019 award
97 shares
Shares issuable from 78 REUs granted April 25, 2019 under the 2018 Equity Incentive Plan
REU-related shares from 2022 award
23 shares
Shares issuable from 18 REUs granted April 1, 2022 under the 2018 Equity Incentive Plan
Key Terms
restricted stock units ("RSUs"), restricted equity units ("REUs"), 2023 Equity Incentive Plan, 2018 Equity Incentive Plan, +1 more
5 terms
restricted stock units ("RSUs") financial
"Includes 80 shares of Class A common stock, par value $0.001 per share (the "Class A common stock"), of Beneficient issuable upon the settlement of an award of 80 restricted stock units ("RSUs")"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
restricted equity units ("REUs") financial
"Includes 97 shares of Class A common stock issuable upon the settlement of an award of 78 restricted equity units ("REUs") granted"
2023 Equity Incentive Plan financial
"RSUs granted pursuant to Beneficient 2023 Equity Incentive Plan ("2023 Equity Incentive Plan") to Peter T. Cangany, Jr."
2018 Equity Incentive Plan financial
"REUs granted pursuant to The Beneficient Company Group, L.P. 2018 Equity Incentive Plan ("2018 Equity Incentive Plan")"
Section 16 of the Securities Exchange Act of 1934 regulatory
"this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934"
A provision of federal securities law that requires company insiders—directors, officers and large shareholders—to publicly report their stock holdings and trades and to surrender any “short-swing” profits from purchases and sales within a six-month window. It acts like a rule that forces leaders to announce their trades and prevents quick buy-sell windfalls, giving investors transparency into insider activity and reducing opportunities for unfair gain.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Beneficient (BENF) director Peter T. Cangany, Jr. report on this Form 4?
He reported a purchase of 18,868 shares of Beneficient Class A Common Stock on September 15, 2026 in an open-market or private transaction at $1.06 per share, increasing his reported direct holdings.
Does this Beneficient (BENF) Form 4 indicate use of a Rule 10b5-1 trading plan?
No. The document-level Rule 10b5-1 checkbox is not marked as affirmative, and the filing does not state that the 18,868-share purchase on September 15, 2026 was made under a Rule 10b5-1 trading plan.
What equity incentive awards are referenced for Peter T. Cangany, Jr. in Beneficient (BENF)?
The footnotes state that his direct holdings include shares issuable from 80 RSUs under the 2023 Equity Incentive Plan and REU awards (covering 97 shares and 23 shares) under the 2018 Equity Incentive Plan, subject to vesting schedules through September 1, 2027 and various April dates.
AI-generated analysis. How Rhea-AI works. Not financial advice.
